pepgen.com - PEPG Stock Price
The market trend for PepGen Inc. (PEPG) shares exhibits volatility due to a lack of active selling, although patents for the EDO delivery system create a robust defensive barrier. The current metric stands at 5.30. PepGen Inc. (PEPG) relies on a staff of distinguished neurobiologists motivated by stock options and scientific discovery. The business's technological foundation is based on an innovative oligonucleotide transport method to combat muscular dystrophy.
PepGen Corp (PEPG) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization information:
- debt level and financial liquidity data:
- company profitability and valuation multiples indicators:
PEPG - Company Net Income|Expected Profit PepGen Inc.|PEPG - Market Cap to Net Income|Forward P/E Multiple PepGen Inc.|PEPG - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PepGen Inc|PEPG - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) PepGen|PEPG - Net earnings per share for the trailing year|Quarterly EPS earnings growth pepgen.com|PEPG - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year PepGen Inc.
Analysis of all company metrics:PepGen PEPG
Price captures the current market consensus regarding the value of a single asset, merging investor expectations and the business's fundamental value into a single equilibrium point. For PepGen Inc. (PEPG), the price action reflects the market's sensitivity to successes in RNA therapy delivery amid fierce technological competition within the neuromuscular pathology treatment sector.
Analysis of competing companies
Price Chart Biogen Inc. (BIIB)|NBIX: Quote Chart|Stock Price RGC (Regencell Bioscience Holdings Limited)|Axsome (AXSM) - Market Price|ACAD - Price Chart|Quote Chart XENE|VKTX: Stock Price|Price Rate Chart supernus.com SUPN|Price Chart Catalyst Pharmaceuticals, Inc.|Share Price DNLI (Denali)|Stock Price HRMY|BHVN - Market Price|Amylyx Pharmaceuticals - Stock Quotes|Stock Price trevitherapeutics.com TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex)|CeriBell Corp (CBLL) - Price Chart|Market Price Prothena Corporation plc (PRTA)|Price Chart Alector Inc.|annexonbio.com - Quote Chart|Stock Price OMER|NGNE - Market Price|Price Chart AC Immune Corp ACIU|VYGR (Voyager Corp) - Quote Chart|Neumora Therapeutics - Stock Price|Price Rate Chart scilexholding.com (SCLX)|TVGN: Stock Price|Market Price Alpha Cognition Inc. (ACOG)|Price Chart Cognition Therapeutics|Share Price IKT (Inhibikase Pharma)|Stock Quotes SAVA (Cassava Sciences, Inc.)|ASRT (assertiotx.com) - Price Performance Chart|Stock Price COYA (Coya Therapeutics)|Market Chart VistaGen Therapeutics, Inc. (VTGN)|OVID - Price Chart|ABOS (Acumen Pharmaceuticals, Inc) - Share Price|CRVO: Stock Price|Stock Quotes Alterity Therapeutics Limited|Stock Quotes CLNN|Jupiter Neurosciences, Inc. (JUNS) - Market Chart|Price Chart Relmada (RLMD)|ANVS: Quote Chart|Stock Price GRCE (Grace Therapeutics)|fireflyneuro.com (AIFF) - Market Price|KLTO - Price Chart|Quote Chart NRSN|RVPH: Stock Price|Price Rate Chart MetaVia MTVA|Price Chart NeurAxis, Inc.|Share Price HSDT (Helius Medical Technologies Inc.)|Stock Price PASG|NEUP - Market Price|Minerva Neurosciences Corp - Stock Quotes|Stock Price Athira Pharma Corp ATHA|ADXN - Price Chart|Price Performance Chart ALZN (Alzamend Neuro, Inc.)|cyclerion.com (CYCN) - Price Chart|Market Price Protagenic Therapeutics, Inc. (PTIX)|Price Chart Pasithea Therapeutics Corp|Cortigent Medical - Quote Chart|Stock Price ATXI|BCLI - Market Price|Price Chart Cara Therapeutics CARA|CHRO (Chromocell Therapeutics Corp) - Quote Chart|Eliem - Stock Price|Price Rate Chart Intra-Cellular Therapies (ITCI)|LBPH: Stock Price|Market Price marinuspharma.com (MRNS)|Price Chart NKGen Biotech|Share Price NRBO (NeuroBo Pharmaceuticals Inc)|Stock Quotes SAGE (Sage Therapeutics, Inc)|SNPX (Synaptogenix, Inc) - Price Performance Chart|Stock Price TRVN (Trevena, Inc.)|Market Chart Vigil Neuroscience Inc. (VIGL)|WENA - Price Chart|CERE (Cerevel Therapeutics Inc) - Share Price
